Schedule 13D ownership disclosure
Armata Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 04216R102
Event date: 2022-05-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 57,345,794
- Percent of class
- 74.9300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-22-020324
- Form type
- SC 13D
- Filer
- Entasis Therapeutics Holdings Inc.
- CIK
- CIK 1724344
- Filed
- May 24, 2022
- Reporting period
- May 23, 2022
- Description
- Schedule 13D beneficial ownership